Semaglutide

Semaglutide is a recombinant DNA produced polypeptide analog of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents.

Online Inquiry

Specification Technical Data Related Products Customer reviews and Q&A Useful Tools Publications

CAT#	10-101-325
Chemical Structure
CAS	910463-68-2
Synonyms/Alias	Sermaglutide; UNII-53AXN4NNHX; NNC 0113-0217; 53AXN4NNHX
M.F/Formula	C187H291N45O59
M.W/Mr.	4113.57
Application	The treatment of type 2 diabetes
Appearance	White to off-white powder
Purity	≥ 98% (or refer to the Certificate of Analysis)
Activity	Agonist
Target	Glucagon Receptor

CAT#	Product Name	Inquiry
10-101-218	Calcitonin eel	Inquiry
10-101-02	Alarelin acetate	Inquiry
10-101-286	(2S)-3-[4-({[(2,2-Dichloroethenyl)oxy]sulfonyl}oxy)phenyl]-Fmoc-2-aminopropanoic acid	Inquiry
10-101-192	Felypressin Impurity E	Inquiry
HB00090	Fmoc-L-Thr(β-D-GlcNAc(Ac)3)-OH	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.